| |
| |
|
| Insider
Information: |
Tullis James L L |
| Relationship: |
Director |
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
375,574 |
|
|
Indirect Shares
|
4,922,801 |
|
|
| Direct
Value |
$2,961,366 |
|
|
|
Indirect Value
|
$18,064,699 |
|
|
| Total
Shares |
5,298,375 |
|
|
| Total
Value |
$21,026,064 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
15
|
|
Stock
price went up :
|
2
|
5
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 119.1%
|
755.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crane Holdings, Co |
CXT |
Director |
2023-11-30 |
4,780 |
2023-11-30 |
1,001 |
Premium* |
|
|
Alphatec Holdings, Inc. |
ATEC |
|
2023-09-11 |
171,962 |
2023-09-11 |
1,569,859 |
Premium* |
|
|
Electrocore, Inc. |
ECOR |
Director |
2020-04-14 |
172,504 |
2020-04-14 |
1,829,302 |
Premium* |
|
|
Exagen Inc. |
XGN |
Director |
2021-08-05 |
21,348 |
2021-08-05 |
1,521,640 |
Premium* |
|
|
Crane Co |
CR |
Director |
2023-05-31 |
4,980 |
2023-05-31 |
999 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
138 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XGN |
Exagen Inc. |
Director |
– • • |
2020-12-11 |
4 |
S |
$13.04 |
$97,775 |
I/I |
(7,500) |
1,567,672 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-12-10 |
4 |
S |
$14.03 |
$140,300 |
I/I |
(10,000) |
1,575,172 |
0 |
- |
|
| ATEC |
Alphatec Holdings, Inc. |
Director |
– • – |
2021-02-23 |
4 |
OE |
$3.50 |
$2,664,543 |
I/I |
761,298 |
1,584,776 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-09-11 |
4 |
S |
$12.40 |
$186,000 |
I/I |
(15,000) |
1,585,275 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-08-18 |
4 |
S |
$14.52 |
$30,221 |
D/D |
(2,082) |
1,600,275 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-08-14 |
4 |
S |
$16.95 |
$195,052 |
I/I |
(11,507) |
1,602,357 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-06-09 |
4 |
S |
$12.77 |
$81,175 |
I/I |
(6,304) |
1,613,864 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-05-28 |
4 |
S |
$11.93 |
$26,724 |
I/I |
(2,240) |
1,620,168 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-05-27 |
4 |
S |
$12.57 |
$20,055 |
I/I |
(1,595) |
1,622,408 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-05-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,162) |
1,624,003 |
0 |
- |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2020-03-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(164,420) |
1,625,165 |
0 |
- |
|
| ECOR |
Electrocore, Inc. |
Director |
– • – |
2020-04-14 |
4 |
B |
$0.85 |
$1,499,999 |
I/I |
1,764,705 |
1,764,705 |
2.1 |
% |
|
| XGN |
Exagen Inc. |
Director |
– • • |
2019-09-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,792,821 |
1,789,585 |
0 |
- |
|
138 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
